ScImage will highlight features of its PicomEnterprise solution, a Web-based enterprise imaging solution that captures, stores, distributes and archives radiology and cardiology image exams from reportedly any DICOM and many non-DICOM devices.

With built-in visualization tools, PicomEnterprise renders images for cardiac CT, cardiac cath, echocardiography, stress echo and has digital subtraction angiography. Reporting tools include hemo dynamic reporting, plus stress and holter reporting from existing reporting solutions.

Emageon will feature its RadSuite Express, reportedly a low-cost PACS solution complete with advanced visualization and 3D capabilities tailored for small to mid-sized hospitals and clinics.

This turnkey solution provides physicians in smaller facilities access to the same high-end, multidisciplinary 3D imaging tools used by radiology, cardiology, orthopedic, neurology and emergency specialists in some of the top-ranked healthcare facilities in America.

Carestream Health will demonstrate the latest features of its KODAK CARESTREAM PACS that include dynamic streaming capabilities to enhance the rapid delivery of images to clinicians in on-site and remote locations. The PACS platform offers optional integrated applications such as image fusion, orthopedic surgical templating, 3D imaging and advanced cardiac features.

3mensio Medical Imaging’s 3viseon 3D imaging workstation reportedly allows the radiologist to quickly deliver accurate results to a wide array of medical specialists, such as cardiologists and surgeons, accommodating the increasing demand for 3D images to facilitate treatment planning.

The system includes interactive and through presets. It also has a variety of smart 2D and 3D functions that make communication and collaboration with other specialists very easy, according to the company.

Company website: www.3mensio.com

October 18, 2007 - Hologic will demonstrate at RSNA 2007, its MammoSite, a targeted radiation therapy that works from the inside, meaning that a higher daily dose can be used for a shorter period of time, five days versus five to seven weeks.

Hologic’s R2 Computer-Aided Detection (CAD) solutions reportedly give users the most sophisticated pattern recognition software to help find cancers with greater certainty at an earlier stage.

R2 technology was the first CAD system approved by the FDA for film-based mammography in 1998 and for digital mammography in 2001, according to the commpany. It is reportedly estimated that more than ten million women had their mammograms interpreted with the aid of R2's CAD technology in the last 12 months.

Company website: www.hologic.com

Hologic will demonstrate MammoSite, a targeted radiation therapy solution that works from the inside, meaning that a higher daily dose can be used for a shorter period of time, five days versus five to seven weeks. MammoSite places the radiation source inside the lumpectomy cavity, delivering radiation to the area where cancer is most likely to recur. The therapy is given on an outpatient basis. No hospital stay is required.

October 18, 2007 - The American College of Radiology (ACR) recently reported that the recent Annual Report to the Nation on the Status of Cancer credits improved screening techniques and more effective treatment for the noticeable drop in national cancer mortality rates.

October 18, 2007 - SenoRx Inc. announced that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its SenoSonix System, an integration of its EnCor breast biopsy system with a state-of-the-art ultrasound imaging system, incorporating SenoRx's EnCor vacuum-assisted biopsy technologies with an ultrasound system developed and sold by Ultrasonix Medical Corporation of Canada.

October 18, 2007 – TomoTherapy Inc. developer, of the TomoTherapy Hi-Art treatment system for helical intensity-modulated radiation therapy (IMRT), announced an alliance with PTW, provider of advanced dosimetry and quality assurance equipment for radiation therapy, enabling TomoTherapy treatment centers worldwide to verify patient-specific treatment plans reportedly with added convenience and efficiency.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now